Prophylactic antibiotic use in acellular dermal matrix-assisted implant-based breast reconstruction

Area of Science:

• Plastic Surgery
• Surgical Oncology
• Infectious Disease

Background:

• Acellular dermal matrix (ADM) is frequently used in implant-based breast reconstruction.
• Prophylactic antibiotics are standard but optimal regimens are not established.
• This study evaluates different antibiotic protocols in ADM-assisted breast reconstruction.

Purpose of the Study:

• To compare the efficacy of various prophylactic antibiotic regimens.
• To determine the impact of antibiotic duration on patient outcomes.
• To identify the best antibiotic strategy for ADM-assisted implant-based breast reconstruction.

Main Methods:

• Retrospective, multicentre study of 105 patients (122 reconstructions) from 2010-2014.
• Analysis of prophylactic antibiotic regimens, duration, wound infection, implant loss, seroma, and therapeutic antibiotic use.
• Statistical comparison of outcomes based on antibiotic regimen and duration.

Main Results:

• Four prophylactic antibiotic regimens and three duration groups were analyzed.
• No statistically significant differences were observed in implant loss, wound infection, seroma, or need for therapeutic antibiotics across groups.
• Neither the specific regimen nor the duration of prophylactic antibiotics impacted key outcomes.

Conclusions:

• Current prophylactic antibiotic regimens show no significant difference in outcomes for ADM-assisted implant-based breast reconstruction.
• Further research is needed to establish evidence-based guidelines.
• Clinical practice may benefit from standardized, simplified antibiotic protocols.